glycopyrrolate vs tiotropium
Side-by-side comparison of glycopyrrolate and tiotropium Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Seebri, Lonhala
Spiriva
Glycopyrrolate injection reduces body secretions before and during surgery. It can also help manage peptic ulcers in adults when quick action is needed.
STIOLTO RESPIMAT is a medicine that combines two drugs to help people with COPD breathe easier. It is used daily to keep airways open.
This medicine can help reduce saliva and other secretions before surgery. It can also help control stomach acid. Glycopyrrolate can also treat peptic ulcers in adults when a quick effect is needed or when you can't take pills.
STIOLTO RESPIMAT is used to treat chronic obstructive pulmonary disease (COPD). COPD includes chronic bronchitis and emphysema. This medicine helps you breathe better over a long period. It is not for sudden breathing problems.
Glycopyrrolate blocks the action of a chemical called acetylcholine. This chemical can cause increased saliva, stomach acid, and other body fluids. By blocking acetylcholine, glycopyrrolate reduces these secretions.
This medicine contains two drugs that work in different ways. Tiotropium helps to relax the muscles around your airways, opening them up. Olodaterol also opens airways by relaxing airway muscles.
- • Dry mouth
- • Trouble urinating
- • Blurred vision
- • Increased heart rate
- • Decreased sweating
- • Common cold
- • Cough
- • Back pain
- Difficulty breathing 1,000
- Asthma 793
- Wheezing 674
- Cough 626
- Pneumonia 538
- Using the medicine the wrong way 23,320
- Difficulty breathing 22,319
- Asthma 10,817
- Medicine not working 9,386
- Cough 8,611
This medicine contains benzyl alcohol, which can be harmful to newborns. If you have glaucoma, trouble urinating, or a blockage in your stomach or intestines, you should not take this medicine for peptic ulcer treatment.
LABA medicines like the one in STIOLTO RESPIMAT can be dangerous for people with asthma if they don't also use an inhaled steroid medicine. Do not use STIOLTO RESPIMAT to treat sudden COPD symptoms. Using too much STIOLTO RESPIMAT can cause serious heart problems and may be fatal. If you have a bad reaction, like swelling or trouble breathing, stop using STIOLTO RESPIMAT right away.
Tell your doctor if you are pregnant or breastfeeding. It is not known if glycopyrrolate will harm an unborn baby. This medicine may also reduce breast milk production.
Tell your doctor if you are pregnant or plan to become pregnant. It is not known if STIOLTO RESPIMAT will harm your unborn baby. Talk to your doctor about the risks and benefits of using this medicine during pregnancy.
Also Compare — Nearby Drugs
Compare glycopyrrolate with
Compare tiotropium with
How to Read This glycopyrrolate vs tiotropium Comparison
glycopyrrolate is classified in the Long-Acting Muscarinic Antagonist (LAMA) drug class, while tiotropium sits within the Long-Acting Muscarinic Antagonist (LAMA) class. Because both drugs share the same classification, they are often considered interchangeable in theory — but clinical outcomes rarely track that cleanly. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, glycopyrrolate has 3,631 submissions while tiotropium has 74,453. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between glycopyrrolate and tiotropium — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.